CORT Q1 2018 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$58M+108.9% YoY

Gross Profit

$56M98.0% margin

Operating Income

$21M36.4% margin

Net Income

$17M30.3% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+8.2%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$34M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$243M

Total Liabilities

$28M

Stockholders' Equity

$215M

Cash & Equivalents

$140M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$28M	+108.9%
Gross Profit	$56M	$27M	+109.6%
Operating Income	$21M	$5M	+342.9%
Net Income	$17M	$4M	+297.9%